| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 3, 2024Virtual Press Office and PR Newswire: General Trade show news
Michael Poku, MD, MBA, Participates on Panel: "Understanding the Value of Social Care" SCOTTSDALE, Ariz., June 3, 2024 /PRNewswire/ -- Equality Health, a national leader in value-based care with...
-
Jun 3, 2024Virtual Press Office and PR Newswire: General Trade show news
GIGABYTE, the world's leading computer brand, announced GIGABYTE AI TOP, a groundbreaking solution for local AI on the launch event one day prior to COMPUTEX 2024. Eddie Lin, CEO of GIGABYTE...
-
Jun 3, 2024Virtual Press Office and PR Newswire: General Trade show news
Leader in IC design services Microip Inc. will exhibit at the esteemed COMPUTEX 2024 with its innovative "AI Design Technology Services" and "Complete IC Design Solutions." The products offered by...
-
Jun 3, 2024Virtual Press Office and PR Newswire: General Trade show news
Aligned with COMPUTEX 2024, Primax Showcases 3 Senses in one Integration Solutions TAIPEI, June 3, 2024 /PRNewswire/ -- Primax Electronics Ltd., a leader in 3 senses in 1 (interface, visual, and...
-
Jun 3, 2024Virtual Press Office and PR Newswire: General Trade show news
With performance options that deliver from 248 to 1,705 TOPS, the NVIDIA-Certified System delivers unprecedented power for enterprises to future-proof edge AI infrastructure. TAIPEI, June 3, 2024...
-
Jun 2, 2024Virtual Press Office and PR Newswire: General Trade show news
MSI, a leading global server provider, will introduce its latest server platforms based on the 4th Gen AMD EPYC™ processors at Computex 2024, booth #M0806 in Taipei, Taiwan, from June 4-7. These...
-
Jun 1, 2024Virtual Press Office and PR Newswire: General Trade show news
On June 1st, 2024, Immunofoco Biotech, a company dedicated to developing cell therapy products for solid tumors, announced that the clinical research data for two of its products have been...
-
Jun 1, 2024Virtual Press Office and PR Newswire: General Trade show news
Poster presentation features the interim data from an ongoing Phase 1b clinical trial of TU2218 plus Keytruda combination therapy in patients with advanced solid tumors A 40% overall response rate...
-
May 31, 2024Virtual Press Office and PR Newswire: General Trade show news
Vivacelle is advancing a robust pipeline of therapies for shock and trauma-induced conditions Vivacelle's pipeline is led by VBI-S, a Phase 3-ready asset designated for the treatment of...
-
May 31, 2024Virtual Press Office and PR Newswire: General Trade show news
New formulation showed non-inferiority to intravenous administration in fourth positive Phase 3 study in RYBREVANT® clinical program Longer overall survival, progression-free survival and...
